Paper33192565
Drug Discovery and Development of Novel Therapeutics for Inhibiting TMAO in Models of Atherosclerosis and Diabetes.
Steinke I and 5 others. Front Physiol, 2020. Cited by 34 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Drug Discovery and Development of Novel Therapeutics for Inhibiting TMAO in Models of Atherosclerosis and Diabetes. Papers, record 33192565. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33192565
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Drug Discovery and Development of Novel Therapeutics for Inhibiting TMAO in Models of Atherosclerosis and Diabetes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,721,934 | Functional activity of the mouse flavin-containing monooxygenase forms 1, 3, and 5. | J Biochem Mol Toxicol | 2007 | https://conductscience.org/library/papers/17721934 | PubMed |
| 2 | 31,543,404 | Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction. | Cell Metab | 2019 | https://conductscience.org/library/papers/31543404 | PubMed |
| 3 | 15,298,340 | Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients. | Diabetologia | 2004 | https://conductscience.org/library/papers/15298340 | PubMed |
| 4 | 16,488,120 | Insulin in flavin-containing monooxygenase regulation. Flavin-containing monooxygenase and cytochrome P450 activities in experimental diabetes. | Eur J Pharm Sci | 2006 | https://conductscience.org/library/papers/16488120 | PubMed |
| 5 | 28,588,431 | Microbial trimethylamine-N-oxide as a disease marker: something fishy? | Microb Ecol Health Dis | 2017 | https://conductscience.org/library/papers/28588431 | PubMed |
| 6 | 28,328,981 | Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. | PLoS One | 2017 | https://conductscience.org/library/papers/28328981 | PubMed |
| 7 | 26,722,518 | Oxidative stress contributes to abnormal glucose metabolism and insulin sensitivity in two hyperlipidemia models. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26722518 | PubMed |
| 8 | 31,276,455 | Coronary heart disease and intestinal microbiota. | Coron Artery Dis | 2019 | https://conductscience.org/library/papers/31276455 | PubMed |
| 9 | 25,532,804 | Diet dominates host genotype in shaping the murine gut microbiota. | Cell Host Microbe | 2015 | https://conductscience.org/library/papers/25532804 | PubMed |
| 10 | 11,259,343 | Trimethylaminuria: the fish malodor syndrome. | Drug Metab Dispos | 2001 | https://conductscience.org/library/papers/11259343 | PubMed |
| 11 | 3,677,545 | A genetic polymorphism of the N-oxidation of trimethylamine in humans. | Clin Pharmacol Ther | 1987 | https://conductscience.org/library/papers/3677545 | PubMed |
| 12 | 23,401,498 | Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23401498 | PubMed |
| 13 | 17,319,098 | Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium. | Vasc Health Risk Manag | 2005 | https://conductscience.org/library/papers/17319098 | PubMed |
| 14 | 16,815,377 | Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. | Lancet | 2006 | https://conductscience.org/library/papers/16815377 | PubMed |
| 15 | 20,376,052 | Endoplasmic reticulum stress and atherosclerosis. | Nat Med | 2010 | https://conductscience.org/library/papers/20376052 | PubMed |
| 16 | 30,410,105 | Dietary metabolism, the gut microbiome, and heart failure. | Nat Rev Cardiol | 2019 | https://conductscience.org/library/papers/30410105 | PubMed |
| 17 | 2,405,443 | Genetic polymorphism of trimethylamine N-oxidation. | Pharmacol Ther | 1990 | https://conductscience.org/library/papers/2405443 | PubMed |
| 18 | 3,731,990 | The human intestinal microflora. | Dig Dis Sci | 1986 | https://conductscience.org/library/papers/3731990 | PubMed |
| 19 | 27,297,342 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. | Circulation | 2016 | https://conductscience.org/library/papers/27297342 | PubMed |
| 20 | 23,435,359 | The gut microbiota--masters of host development and physiology. | Nat Rev Microbiol | 2013 | https://conductscience.org/library/papers/23435359 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,351,636 | Gut Microbiota: Cardiovascular Disease Prevention and Targeted Therapies. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351636 | PubMed |
| 42,201,486 | Microbiota-Derived Metabolites in Developmental Programming: Bridging Early-Life Gut Microbiota to Childhood Metabolic Disorders. | Curr Med Sci | 2026 | https://conductscience.org/library/papers/42201486 | PubMed |
| 41,748,989 | Live tissue microbiota and bacterial translocation: mechanisms and translational perspectives in cardiometabolic diseases. | Rev Endocr Metab Disord | 2026 | https://conductscience.org/library/papers/41748989 | PubMed |
| 41,608,868 | Gut microbe-derived trimethylamine shapes circadian rhythms through the host receptor TAAR5. | Elife | 2026 | https://conductscience.org/library/papers/41608868 | PubMed |
| 41,608,402 | Understanding the Relationship Between Cerebrovascular Disease and the Gut Microbiome. | Stroke Vasc Interv Neurol | 2025 | https://conductscience.org/library/papers/41608402 | PubMed |
| 41,383,948 | The role of gut microbiota-derived metabolites in neuroinflammation. | Neuroprotection | 2025 | https://conductscience.org/library/papers/41383948 | PubMed |
| 41,278,968 | Gut Microbe-Derived Trimethylamine Shapes Circadian Rhythms Through the Host Receptor TAAR5. | bioRxiv | 2025 | https://conductscience.org/library/papers/41278968 | PubMed |
| 40,872,762 | The Role of SARS-CoV-2 Nucleocapsid Protein in Host Inflammation. | Viruses | 2025 | https://conductscience.org/library/papers/40872762 | PubMed |
| 39,683,637 | Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota. | Nutrients | 2024 | https://conductscience.org/library/papers/39683637 | PubMed |
| 39,123,239 | Gut matters in microgravity: potential link of gut microbiota and its metabolites to cardiovascular and musculoskeletal well-being. | Nutr Metab (Lond) | 2024 | https://conductscience.org/library/papers/39123239 | PubMed |
| 38,879,769 | Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases. | Cardiovasc Hematol Disord Drug Targets | 2024 | https://conductscience.org/library/papers/38879769 | PubMed |
| 38,112,268 | Pravastatin promotes type 2 diabetes vascular calcification through activating intestinal Bacteroides fragilis to induce macrophage M1 polarization. | J Diabetes | 2024 | https://conductscience.org/library/papers/38112268 | PubMed |
| 38,003,343 | The AKI-to-CKD Transition: The Role of Uremic Toxins. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003343 | PubMed |
| 37,932,654 | Trimethylamine N-oxide promotes oxidative stress and lipid accumulation in macrophage foam cells via the Nrf2/ABCA1 pathway. | J Physiol Biochem | 2024 | https://conductscience.org/library/papers/37932654 | PubMed |
| 37,569,352 | Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569352 | PubMed |
| 37,337,893 | The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review. | Biomol Biomed | 2023 | https://conductscience.org/library/papers/37337893 | PubMed |
| 37,229,456 | Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37229456 | PubMed |
| 36,830,968 | Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases. | Biomedicines | 2023 | https://conductscience.org/library/papers/36830968 | PubMed |
| 36,675,320 | Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675320 | PubMed |
| 36,092,861 | Gut and obesity/metabolic disease: Focus on microbiota metabolites. | MedComm (2020) | 2022 | https://conductscience.org/library/papers/36092861 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP4F3 | 4,051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
| FMO3 | 2,328 | PubTator's text mining | https://conductscience.org/library/genes/2328 | NCBI Gene |
| FMO5 | 2,330 | PubTator's text mining | https://conductscience.org/library/genes/2330 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33192565
GET https://conductscience.org/api/papers/v1/33192565/references?page=2